产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
T975999 | 1403766-80-2 | rel-叔丁基(1R,4R,5S)-5-氨基-2-氮杂双环[2.1.1]己烷-2-羧酸酯, 95% tert-butyl endo-5-amino-2-azabicyclo[2.1.1]hexane-2-carboxylate, 95% |
||
T975996 | 893566-16-0 | rel-叔丁基(1R,5S,6r)-6-(氨基甲基)-3-氮杂双环[3.1.0]正己烷-3-羧酸酯, 98% tert-butyl exo-6-(aminomethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate, 98% |
||
R741969 | 2381089-83-2 | Retatrutide, ≥98% Retatrutide, ≥98% |
C221H342N46O68 | |
R964179 | 1215654-26-4 | RS100329 盐酸盐, ≥98% RS100329 hydrochloride, ≥98% |
C20H26ClF3N4O3 | |
R976254 | 1798781-96-0 | RuPhos Pd(crotyl)Cl, 98% RuPhos Pd(crotyl)Cl, 98% |
||
S920374 | 63701-56-4 | S(−)-Baclofen hydrochloride, ≥98% (TLC) S(−)-Baclofen hydrochloride, ≥98% (TLC) |
C10H12ClNO2 · HCl | |
S797188 | 13849-08-6 | S-(+)-印度枸橘素, 10mM in DMSO S-(+)-Marmesin, 10mM in DMSO |
C14H14O4 | |
S860565 | 13849-08-6 | S-(+)-印度枸橘素, >99% S-(+)-Marmesin, >99% |
C14H14O4 | |
S938711 | 145783-12-6 | S-丙基-2-硫代巴比妥酸, 97% S-Propyl-2-thiobarbituric Acid, 97% |
C7H10N2O2S | |
S970024 | 30044-51-0 | S-叔丁基巯基L-半胱氨酸, 96% S-tert-Butylmercapto-L-cysteine, 96% |
C7H15NO2S2 | |
C970496 | 694495-47-1 | S-盐酸西那卡塞, 98% ent-Cinacalcet Hydrochloride, 98% |
C22H23ClF3N | |
S996002 | 1491917-83-9 | Sacituzumab govitecan, 98% Sacituzumab govitecan, 98% |
||
S982483 | 80565-58-8 | Sari59-801, ≥99% Sari 59-801, ≥99% |
C18H23N3O2 | |
S768404 | 1189541-98-7 | Sarilumab (anti-IL-6Rα), 98% Sarilumab (anti-IL-6Rα), 98% |
||
S982304 | 152239-46-8 | SB 204741,5-HT 2B受体拮抗剂, 98% SB 204741, 98% |
C14H14N4OS | |
S990324 | 209481-20-9 | SB271046, 98% SB271046, 98% |
C20H22ClN3O3S2 | |
C996750 | 1451272-71-1 | SBI-425, 95% 5-((5-CHLORO-2-METHOXYPHENYL)SULFONAMIDO)NICOTINAMIDE, 95% |
C13H12ClN3O4S | |
S938696 | 1415246-55-7 | SCHEMBL14237864, ≥98% SCHEMBL14237864, ≥98% |
C39H64N4O9 | |
S938741 | 161485-82-1 | SCHEMBL18811643, ≥98% SCHEMBL18811643, ≥98% |
C24H36N2O6 | |
S750090 | 928821-40-3 | Seladelpar Lysine dihydrate, Seladelpar Lysine dihydrate, |
C27H41F3N2O9S |